SCHEMBL17248267

SCHEMBL17248267

c1ccc(-c2cccc(-n3c4ccccc4c4ccc5c6ccccc6n(-c6cccc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)c6)c5c43)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
ATM Q13315 2/20 0.51
KDM4E B2RXH2 1/20 0.51
TSPO P30536 3/20 0.40
KMT2A Q03164 3/20 0.38
IL1R1 P14778 1/20 0.38
HDAC4 P56524 1/20 0.37
ALDH1A1 P00352 2/20 0.37
HTT P42858 2/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 1/20 0.37
FAAH O00519 1/20 0.36
HSP90AA1 P07900 1/20 0.36
PKM P14618 1/20 0.36
MGLL Q99685 1/20 0.36
PTGER4 P35408 1/20 0.35
HTR1A P08908 1/20 0.35
HTR7 P34969 1/20 0.35
DNM1 Q05193 1/20 0.34
MAPK8 P45983 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797671 1.00 L3MBTL1 (0.51) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19652936 1.00 L3MBTL1 (0.51) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19797659 1.00 L3MBTL1 (0.51) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19652690 1.00 L3MBTL1 (0.51) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19653618 1.00 L3MBTL1 (0.51) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19769440 0.99 L3MBTL1 (0.50) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19863524 0.99 L3MBTL1 (0.50) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19653636 0.99 L3MBTL1 (0.50) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19769509 0.99 L3MBTL1 (0.50) L3MBTL1ATMKDM4ETSPOKMT2A
SCHEMBL19769478 0.99 L3MBTL1 (0.50) L3MBTL1ATMKDM4ETSPOKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
EP-2933851-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2017-05-10 EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 L3MBTL1 74/4885ATM 3768/4885KDM4E 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.